AusCann Group (ASX:AC8) completes phase one THC:CBD study

AusCann Group (ASX:AC8) completes phase one THC:CBD study

The market Herald reports…AusCann Group (AC8) has completed its first clinical study for its THC and CBD combination hard-shell capsulesAusCann was evaluating the… Read More… The post AusCann Group (ASX:AC8) completes phase one THC:CBD study first appeared on Cannabis Law Report.

Excerpt only …
READ MORE BELOW
Source : CANNANNEW REPORT
Link to original : AusCann Group (ASX:AC8) completes phase one THC:CBD study
reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.